Commentary: Predictors and Impact of Postoperative 30-Day Readmission in Glioblastoma. Dono A, Rodriguez-Armendariz AG, Esquenazi Y. Neurosurgery 2022 Sep 15. pii: 00006123-990000000-00384.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dono A, Rodriguez-Armendariz AG, Esquenazi Y. Commentary: Predictors and Impact of Postoperative 30-Day Readmission in Glioblastoma. Neurosurgery 2022 Sep 15. pii: 00006123-990000000-00384.
PMID: 36106886